Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

Title
Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 9, Issue 10, Pages 1543-1546
Publisher
Future Medicine Ltd
Online
2008-10-14
DOI
10.2217/14622416.9.10.1543

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now